SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

FDA approval of Bysanti for bipolar I disorder and schizophrenia is driving Vanda Pharmaceuticals' surge, with the community anticipating a significant re-rating and potential buyout offers. Investors are excited by the drug's long-term exclusivity and the broader pipeline, including the mega-blockbuster potential of Tradipitant.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is trending as the community actively discusses its unique move-to-earn utility and expresses long-term optimism for a rebound, despite its current low valuation.

Moo Deng

Moo Deng is trending with explosive price action and massive trading volume, sparking widespread community excitement and speculation for parabolic gains, as traders eye its low market cap for continued upward momentum.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

The YieldMax Ultra Option Income Strategy ETF ($ULTY) is a major talking point following its recent 1-for-10 reverse stock split and a strategic shift aiming for net asset value (NAV) stability over ultra-high payouts, sparking mixed reactions among investors grappling with past performance versus future potential.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian (TEAM) is experiencing a sharp sell-off in the broader SaaS sector, driven by market fears that rapidly advancing AI models could disrupt or replace core enterprise software, though many in the community contend its complex platforms remain indispensable for large organizations.

TOSHI

TOSHI is trending as its community anticipates a significant price breakout, with many citing bullish technical patterns like the "cup and handle" formation and an overall shift toward altcoin season. Enthusiastic investors are actively discussing its potential to rally, often linking its performance to Bitcoin's movements and its role as the "face of Base" and Coinbase.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

ASP Isotopes Inc

ASP Isotopes is trending amidst heightened anticipation for the QLE spin-off and recent updates on the Renergen Helium Project, which proponents believe will unlock significant value. However, community discussions also reveal widespread frustration regarding persistent delays in isotope production and concerns over management's overall execution.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending as the community debates its muted stock reaction to the Supreme Court's tariff ruling, intensified by recent brand scrutiny over a "see-through" product line and public concerns from its founder regarding board leadership.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind (MNKD) is trending amid high anticipation for its upcoming earnings and an Oppenheimer conference, with the community keenly focused on potential FDA approvals for pediatric Afrezza and the Furoscix autoinjector. Investors are debating if these catalysts, alongside a recent Afrezza label update and its launch in India, will finally propel the diversified inhaled therapies company beyond its historical price range.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

AFJK is trending as a low-float SPAC whose extended merger timeline has ignited significant community discussion about its potential for a short squeeze and highly volatile upward price action, mirroring recent speculative moves in other similar "Chinese runners."

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

U.S. President Donald Trump departs after speaking during a House Republican retreat at The John F. Kennedy Center for the Performing Arts on January 06, 2026 in Washington, DC

Bombardier, General Dynamics Caught In Crosshairs Of Trump's New Tariff Fury On Canada Over Business Jets

Trump warned of a 50% tariff on Canadian-made aircraft and floated broader trade penalties if Canada moves ahead with China.

Equity

Trump warned of a 50% tariff on Canadian-made aircraft and floated broader trade penalties if Canada moves ahead with China.


Bombardier Cl B Sv

Bombardier is gaining attention as robust financial results and new aircraft orders are overshadowed by market volatility. Community discussion centers on the potential economic impact of renewed tariff threats from Donald Trump against Canada, contrasting with optimism surrounding Bombardier's strong fundamentals and increasing defense sector involvement.

Current Price	$276.88
Prev Close	$275.84
Open	$274.76
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

BBD.B.TSX
Bombardier Cl B Sv

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BBD.B.TSX News

BBD.B.TSXBombardier Cl B Sv